Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Palestinian Refugee Camp Burj Barajneh in Beirut, Lebanon. humanitarian bodies not only face the obvious security risks of reaching people in need, they also have to deal with the growing bureaucracy involved in getting medicines to them.

Supplying medicines to refugees: a logistical nightmareSubscription

During conflicts, humanitarian bodies not only face the obvious security risks of reaching people in need, they also have to deal with the growing bureaucracy involved in getting medicines to them.

More features

The British Society of Rheumatology (BSR) is creating its own evidence database to track the efficacy and long-term safety of new biosimilar products coming on to the UK market.

Rheumatologists launch database to track efficacy and safety of biosimilar productsSubscription

The British Society of Rheumatology (BSR) is creating its own evidence database to track the efficacy and long-term safety of new biosimilar products.

Jim O’Neill (pictured), chair of the UK’s independent Review of Antimicrobial Resistance, said that an innovation fund worth up to US$2bn could be set up to encourage the pharmaceutical industry to develop new classes of antibiotics

US$2bn global innovation fund proposed to tackle antimicrobial resistanceSubscription

A worldwide innovation fund worth up to US$2bn could be set up to encourage the pharmaceutical industry to search for and develop new classes of antibiotics.

Community pharmacists support new medicine service, research suggestsSubscription

Community pharmacists generally support the new medicine service because they think it will benefit patients, according to new research.

There is a consistent dose-response relationship between paracetamol use and risk of mortality or cardiovascular, gastrointestinal or renal adverse events, new research finds

Paracetamol use linked with cardiovascular risk and other adverse eventsSubscription

Researchers have discovered a consistent dose-response relationship between paracetamol use and risk of mortality or cardiovascular, gastrointestinal or renal adverse events.

GSK and Novartis wrap up multibillion pound business dealSubscription

GlaxoSmithKline and Novartis have completed their three-prong multibillion pound business transaction, the companies have announced.

Elisabeth Hoff, World Health Organization (WHO) country representative in Syria, said that despite the ongoing violence in Syria, the WHO and its partners, are delivering life-saving medicines to millions

WHO appeals for US$1bn to help deliver medical aidSubscription

The World Health Organization is appealing for more than US$1bn to meet the health needs of 21 million people in Syria, Iraq, the Central African Republic and South Sudan.

Scientists have identified an important pathway used by the Ebola virus to gain entry into cells that may lead to new therapeutic approaches.

Viral cell entry holds clue to effective treatment of EbolaSubscription

Scientists have identified an important pathway used by the Ebola virus to gain entry into cells that may lead to new therapeutic approaches.

The use of nonsteroidal anti-inflammatory drugs (NSAIDs) in patients receiving antithrombotic therapy after myocardial infarction (MI) doubles the risk of further heart attacks. In the image, scan of a heart attack.

Safety data prompt calls for a halt on NSAID use in patients with heart diseaseSubscription

The use of nonsteroidal anti-inflammatory drugs in patients receiving antithrombotic therapy after myocardial infarction doubles the risk of further heart attacks, researchers find.

The US Food and Drug Administration (FDA) has fast-tracked the approval of the first histone deacetylase (HDAC) inhibitor to treat patients with multiple myeloma (pictured)

FDA fast tracks approval of panobinostat for multiple myelomaSubscription

The US Food and Drug Administration has fast-tracked the approval of the first histone deacetylase inhibitor to treat patients with multiple myeloma.

Medicines regulators in India have put forward proposals to ensure that consumers know the maximum price that they should be charged for certain medicines. In the image, a pharmacy in Kerala, India

Pharmacists in India to alert customers to maximum price they can be charged for medicinesSubscription

Medicines regulators in India have put forward proposals to ensure that consumers know the maximum price that they should be charged for certain medicines.

Complaints about medicines advertising fall by a thirdSubscription

The number of complaints about medicines advertising made to the safety regulator fell by a third in 2014, according to official figures released on 24 February 2015.

Manchester to get full control of its health spendingSubscription

Health and social care services in Greater Manchester are preparing to break away from centralised control, following a devolution settlement with the UK government.

App wins infection control category of NHS Innovation Challenge AwardsSubscription

A smartphone app that offers up-to-date antibiotic prescribing advice to hospital doctors has won the infection control category in the annual NHS Innovation Challenge Awards.

Licensing deal will allow paediatric HIV drug to be used more widelySubscription

Children with HIV in developing countries will now have access to generic paediatric formulations of raltegravir following a licence agreement with Merck.

The General Pharmaceutical Council (GPhC) is launching an urgent review of controversial community pharmacy premises inspection rankings and has announced that the “satisfactory” category will not appear in the final inspection model.

Pharmacy regulator to review premises ranking systemSubscription

The General Pharmaceutical Council will scrap the ‘satisfactory’ category from community pharmacy premises inspection rankings after concerns that it may be misinterpreted.

Researchers have developed a new nine-component vaccine against human papillomavirus (HPV) which they believe could increase overall protection against cervical cancers from around 70% to 90%, according to a study

Nine-component HPV vaccine aims to prevent 90% of cervical cancersSubscription

Researchers have developed a new nine-component vaccine against human papillomavirus which they believe could increase overall protection against cervical cancers to 90%.

WHO announces new policy guidelines on injection safetySubscription

The World Health Organization wants to see universal adoption of syringes that can only be used once, to address the global problem of unsafe injections.

Pharmaceutical companies violate drug advertising codes, study highlights. The Medicines and Healthcare Products Regulatory Agency (MHRA), pictured, oversees drug advertising in the UK.

Pharmaceutical companies often violate drug advertising codes, study findsSubscription

The pharmaceutical industry’s systems for self-regulation of drug advertising and marketing are weak, according to a study published in PLoS Medicine.

Reduction in antipsychotic use by dementia patients must continue, says CameronSubscription

The government wants to see a “significant” reduction in inappropriate prescribing of antipsychotic drugs to people with dementia in England in the next five years.

Long-acting opioids may carry a higher risk for unintentional overdose than short-acting formulations, study suggests. Morphine sulphate tablets pictured

Risk of unintentional overdose higher for long-acting opioidsSubscription

Patients taking long-acting opioids are more than twice as likely to overdose unintentionally than patients taking short-acting opioids, study finds.

All news

Over the course of a person’s lifetime they will be infected with multiple strains of influenza virus, leaving a specific pattern of antibodies in their blood. In the image, micrograph of the influenza virus

Young people contract flu more frequently than adults aged over 30Subscription

Young people seem to contract influenza every other year on average, while adults over 30 seem to contract flu twice a decade, say researchers.

A new drug candidate known as “eCD4-Ig” has efficiently neutralised 100% of a diverse panel of HIV-1, HIV-2 and simian immunodeficiency virus isolates. In the image,

Drug candidate eCD4-Ig demonstrates durable protection against HIV infectionSubscription

A drug candidate known as “eCD4-Ig” — a fusion of CD4-Ig with a small CCR5-mimetic sulfopeptide — has efficiently neutralised 100% of a diverse panel of HIV-1, HIV-2 and simian immunodeficiency virus isolates.

Study using UK data has observed a protective effect of statins against liver cancer. In the image, dividing cancer cells

UK data confirm protective effect of statins against liver cancerSubscription

A study using data from the UK has observed a protective effect of statins against liver cancer, an effect previously seen in countries with high rates of the disease.

A review finds that pharmacists operate within a highly-regulated environment that creates the potential for moral distress to occur. In the image, pharmacist in a dispensary

Working environment of pharmacists can create ‘moral distress’Subscription

A literature review has found that pharmacists operate within a highly-regulated environment that creates the potential for moral distress to occur.

Wider use of ranibizumab could help prevent sight loss in thousands of US adults with diabetic macular oedema. In the image, retina damage from diabetes

Wider use of ranibizumab would cut incidence of blindness in diabetic macular oedemaSubscription

An economic modelling study published in Ophthalmology suggests that wider use of ranibizumab could help prevent sight loss in thousands of US adults with diabetic eye disease.

Study show that 5 years of creatine at a dose of 10 mg/day does not slow disease progression in patients with early, stable Parkinson's disease

Creatine does not slow progression in Parkinson's disease, study findsSubscription

Five years of creatine at a dose of 10mg/day does not slow disease progression in patients with early, stable Parkinson’s disease, a study published in JAMA shows.

Blood pressure lowering in type 2 diabetics linked with improved mortality

Blood pressure lowering in type 2 diabetics associated with improved mortalitySubscription

New research suggests that a 10mmHg reduction in systolic BP is associated with significant reductions in death, macrovascular events and microvascular events, with relative risk reductions ranging from 11% to 27%.

In patients with Parkinson's disease (PD), levodopa (l-dopa) treatment can induce dyskinesias. In the image, molecular structure of levodopa

Eltoprazine could tackle dyskinesia side effect in Parkinson’s disease, study suggestsSubscription

Researchers have evaluated the use of eltoprazine, a selective partial agonist at the 5-HT1A and 5-HT1B receptors, for its ability to counteract dyskinesias.

More research briefings

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free newsletters.

Jobs from PJ careers

More jobs